The amended dosing regimen was approved based on results from a post hoc analysis of the phase 2 MagnetisMM-3 trial.

Anselamimab is an anti-fibril monoclonal antibody designed to reduce or eliminate amyloid deposits by binding with targets of amino acids on misfolded amyloid fibrils.

Nostrum Labs is recalling all lots within expiry of Sucralfate Tablets 1g as the Company has shut down operations at its US sites and is unable to assure the quality of the product.

This new color is part of a bigger push to phase out artificial dyes, which have raised concerns in recent years.

Fifteen of 20 HLA-matched living donor recipients achieved the primary end point of being immunosuppression-free for more than 2 years.

Longer treatment duration, using semaglutide, higher percentage body fat, and nondiabetic status may be associated with better weight reduction.

HealthDay News — Approved label populations for new drugs are broader than trial populations overall, according to a study published online July 8 in the Annals of Internal Medicine.

For postmenopausal women with overweight or obesity receiving tirzepatide, menopausal hormone therapy linked to increased weight loss.

No significantly increased risks observed for autoimmune disorder, atopic or allergic disorder, neurodevelopmental disorder.

The Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in a Complete Response Letter (CRL) for etripamil nasal spray (Cardamyst ™ ), an investigational ...

The CUP-DIU study explored the relationship between IUD displacement and the use of a menstrual cup in 747 women who consulted for follow-up of their IUD at 2 primary care facilities in Paris.

Arexvy is currently approved to prevent lower respiratory tract disease (LRTD) caused by RSV in individuals aged 60 years and older, and those 50 to 59 years of age who are at increased risk for LRTD ...